S036 Business and Leadership: What Dermatologists Should Know
DESCRIPTION
Medicine is one of the largest Businesses in the world. Most medical training does not involve learning about this important topic. In this session, Dermatologists and trainees will learn about various aspects of Business and Leadership in Medicine and Dermatology.
LEARNING OBJECTIVES
Summarize various business aspects of Dermatology and Medicine
Outline various practice settings for Dermatologists and Trainees
Recognize leadership perspectives in AAD and AMA
SCHEDULE
1:00 PM
How to run a successful Medical Dermatology Practice
Amy J McMichael, MD, FAAD
1:14 PM
How to run a successful Surgical/Cosmetic Dermatology Practice
Roy G. Geronemus, MD, FAAD
1:28 PM
How to run a successful Dermatopathology practice
Tammie C. Ferringer, MD, FAAD
1:42 PM
Coding and billing in Medical Dermatology
Dirk Michael Elston, MD, FAAD
1:56 PM
Coding and billing in Surgical Dermatology
Howard Wooding Rogers, MD, PhD, FAAD
2:10 PM
How to Start and Run a Dermatology Solo Practice
Suzanne McGoey, MD, MPH, FAAD
2:24 PM
How to run a successful Pediatric Dermatology practice
Fernanda Bellodi Schmidt, MD
2:38 PM
How to Run a Successful Dermatology Organization
Mark D. Kaufmann, MD, FAAD
2:52 PM
Teledermatology
George Han, MD, PhD, FAAD
3:06 PM
AI in Dermatology
Faranak Kamangar, MD, FAAD
3:20 PM
Physician Leadership: Perspectives from a former AMA President
Jack S. Resneck Jr., MD, FAAD
3:34 PM
How to get more involved with AAD Leadership
Marta Jane Van Beek, MD, MPH, FAAD
3:48 PM
Q&A
DIRECTOR
Keyvan Nouri, MBA, MD, FAAD
SPEAKERS
Fernanda Bellodi Schmidt, MD
Dirk Michael Elston, MD, FAAD
Tammie C. Ferringer, MD, FAAD
Roy G. Geronemus, MD, FAAD
George Han, MD, PhD, FAAD
Faranak Kamangar, MD, FAAD
Mark D. Kaufmann, MD, FAAD
Suzanne McGoey, MD, MPH, FAAD
Amy J McMichael, MD, FAAD
Jack S. Resneck Jr., MD, FAAD
Howard Wooding Rogers, MD, PhD, FAAD
Marta Jane Van Beek, MD, MPH, FAAD
HANDOUTS
DISCLOSURES
Fernanda Bellodi Schmidt, MD
Abeona Therapeutics – Investigator(Grants/Research Funding); Eli Lilly – Investigator(Grants/Research Funding); Primus Pharmaceuticals – Advisory Board(Honoraria); Timber Pharmaceuticals – Investigator(Grants/Research Funding); VeraDermics Inc. – Advisory Board(Honoraria);
Dirk Michael Elston, MD, FAAD
No financial relationships exist with ineligible companies.
Tammie C. Ferringer, MD, FAAD
No financial relationships exist with ineligible companies.
Roy G. Geronemus, MD, FAAD
Accure, Inc – Stockholder Private Company(No Compensation Received); AVAVA, Inc. – Investigator(No Compensation Received); Sciton Inc. – Investigator(No Compensation Received);
George Han, MD, PhD, FAAD
Aclaris Therapeutics, Inc. – Advisory Board(Honoraria); Alumis – Investigator(Grants/Research Funding); Avillion – Investigator(Grants/Research Funding); Boehringer Ingelheim – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Bristol-Myers Squibb – Advisory Board(Honoraria); Eli Lilly and Company – Advisory Board(Honoraria), Investigator(Grants/Research Funding); First Tracks Biotherapeutics – Advisory Board(Honoraria); Incyte – Investigator(Grants/Research Funding); Incyte Corporation – Advisory Board(Honoraria); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); LearnHealth/LearnSkin – Speaker/Faculty Education(Honoraria); Leo Pharma – Advisory Board(Honoraria); Novartis Pharmaceuticals Corp. – Investigator(Grants/Research Funding); Ortho Dermatologics – Advisory Board(Honoraria); Pfizer Inc. – Speaker(Honoraria); Regeneron Pharmaceuticals, Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Sanofi – Advisory Board(Honoraria); Sanofi Genzyme – Speaker(Honoraria); Sun Pharmaceutical Industries Ltd. – Speaker(Honoraria); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria); UCB – Advisory Board(Honoraria), Speaker(Honoraria);
Faranak Kamangar, MD, FAAD
No financial relationships exist with ineligible companies.
Mark D. Kaufmann, MD, FAAD
Almirall – Consultant (1099 relationship)(Fees); Apogee Therapeutics – Consultant (1099 relationship)(Fees); Biofrontera – Consultant (1099 relationship)(Fees); Botanix Pharmaceuticals – Advisory Board(Fees); CryoCaptures LLC – Stockholder Private Company(Stock); Dermsquared – Stockholder Private Company(Stock); DermTech Inc. – Consultant (1099 relationship)(Fees); Feldan Therapeutics – Consultant (1099 relationship)(Fees); Genius Clinic, Inc – Stockholder Private Company(Stock Options); Incyte – Consultant (1099 relationship)(Fees); Novartis – Consultant (1099 relationship)(Fees); NuVida – Advisory Board(Fees); Oruka Therapeutics – Consultant (1099 relationship)(Fees); Peerwise Medical Corp – Stockholder Private Company(Stock); Pelthos Therapeutics – Consultant (1099 relationship)(Fees); Sanofi/Regeneron – Consultant (1099 relationship)(Fees); SciBASE – Consultant (1099 relationship)(Fees); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Fees); UCB Pharma – Consultant (1099 relationship)(Fees); VeraDermics Inc. – Advisory Board(Fees); Verrica Pharmaceuticals Inc – Consultant (1099 relationship)(Fees); Xtresse – Stockholder Private Company(Stock);
Suzanne McGoey, MD, MPH, FAAD
No financial relationships exist with ineligible companies.
Amy J McMichael, MD, FAAD
Aclaris Therapeutics Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Allergan, Inc. – Consultant(Honoraria); Apogee BioPharm – Advisory Board(No Compensation Received); Arcutis Biotherapeutics – Advisory Board(Honoraria); Bristol-Myers Squibb – Advisory Board(Honoraria); Canfield Scientific, Inc. – Consultant (1099 relationship)(Honoraria); Cassiopea S.p.A. – Investigator(Grants/Research Funding); CeraVe/Valeante – Consultant(Honoraria); Concert Pharmaceuticals – Investigator(Grants/Research Funding); Eli Lilly and Company – Consultant (1099 relationship)(Honoraria); Elsevier Inc. – Other(Patent royalties or other compensation for Intellectual Property Rights); Galderma Laboratories, L.P. – Consultant(Other Financial Benefit); Incyte Corporation – Consultant(Honoraria), Investigator(Grants/Research Funding); Informa – Other(Other Financial Benefit); JAMA – Other(No Compensation Received); Janssen Pharmaceuticals, Inc – Consultant(Honoraria); Johnson & Johnson Consumer Products Company – Consultant(Honoraria); Kenvue – Consultant (1099 relationship)(Honoraria); L'Oreal USA Inc. – Advisory Board(Honoraria); LearnHealth/LearnSkin – Speaker/Faculty Education(Honoraria); Leo Pharma – Consultant (1099 relationship)(Honoraria); McGraw-Hill Companies – Other(Patent royalties or other compensation for Intellectual Property Rights); NAAF – Advisory Board(No Compensation Received); North American Hair Research Society – Board of Directors(No Compensation Received); Nutrafol – Advisory Board(Honoraria); Pelage Pharmaceuticals – Consultant (1099 relationship)(Honoraria); Pfizer Inc. – Consultant(Honoraria), Consultant(Other Financial Benefit); Procter & Gamble Company – Consultant(Honoraria), Investigator(Other Financial Benefit); Revian LTD. – Board of Directors(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Honoraria); UCB – Consultant(Honoraria); UpToDate, Inc – Speaker/Faculty Education(Honoraria); VeraDermics Inc. – Consultant (1099 relationship)(Honoraria);
Keyvan Nouri, MBA, MD, FAAD
iVeena Delivery Systems-Eye Drug Delivery – Stockholder(No Compensation Received); Pfizer Inc. – Stockholder(No Compensation Received);
Jack S. Resneck Jr., MD, FAAD
No financial relationships exist with ineligible companies.
Howard Wooding Rogers, MD, PhD, FAAD
Biofrontera AG – Consultant (1099 relationship)(Fees);
Marta Jane Van Beek, MD, MPH, FAAD
No financial relationships exist with ineligible companies.